Barbara Lam, MD¹, Laura E. Dodge, ScD MPH^2,3*, Siddhant Datta, MD^4*, Rachel P. Rosovsky, MD^5,6, William Robertson^7*, Leslie Lake^8*, Nimia Reyes, MD, MPH^9*, Alys Adamski, PhD, MPH^10*, Karon Abe, PhD^10*, Samuel Panoff^11*, Amanda Pinson^11*, Pavania Elavalakanar, MSc, BSc^2*, Jeffrey I. Zwicker, MD^6,11 and Rushad Patell, MD, MBBS^6,11

¹Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Brookline, MA
²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Harvard T.H. Chan School of Public Health, Boston, MA
⁴Division of Hospital Medicine, Beth Israel Deaconess Medical Center, Boston, MA
⁵Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
⁶Harvard Medical School, Boston, MA
⁷Weber State University, Ogden, UT
⁸National Blood Clot Alliance, Philadelphia, PA
⁹Division of Blood Disorders, Centers for Disease Control & Prevention, Atlanta, GA
¹⁰Division of Blood Disorders/National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
¹¹Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA

Kevin Wang, M.S.^1*, Jackie Kwong, PhD, PharmD¹, Peng Wang, M.A.^1* and Ralph V. Boccia, MD, FACP²

¹Daiichi Sankyo, Inc., Basking Ridge, NJ
²The Center for Cancer and Blood Disorders, Bethesda, MD

Foluso Joy Ogunsile, MD¹, Autumn Beavers, MD^2* and Julie Kanter, MD³

¹Division of Hematology and Oncology, University of Alabama Birmingham, Birmingham, AL
²University of Alabama at Birmingham, Birmingham, AL
³Director, Adult Sickle Cell Program, University of Alabama at Birmingham, Birmingham, AL

Jessica Freydman, PharmD^1*, Maha AlDoughaim, PharmD^2*, Simon Gorelikov, PharmD, BCPS, BCOP^2*, Kimberly Tsou, PharmD^2*, Frances Blevins, PA-C^3*, John Mark Sloan, MD³, Radhika Jhaveri, PharmD, BCOP^4* and David Hughes, PharmD, BCOP^3,4,5

¹Massachusetts General Hospital, Boston, MA
²Boston Medical Center, Boston
³Section of Hematology & Medical Oncology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA
⁴Department of Pharmacy, Boston Medical Center, Boston, MA
⁵Pfizer Inc, New York, NY

Brandon Bungo, MD¹, Lindsey Kalhagen, PA-C^2*, Caroline Laub, APRN^2*, Iwona Boska, APRN, CNP^2*, Anaadriana Zakarija, MD³, Brady L. Stein, MD, MHS⁴ and Karlyn A. Martin, MD⁵

¹Hematology and Medical Oncology, Northwestern University, Chicago, IL
²Hematology/Oncology, Northwestern Medicine, Chicago, IL
³Northwestern University Feinberg School of Medicine, Chicago, IL
⁴Feinberg School of Medicine, Northwestern University, Chicago, IL
⁵Hematology/Oncology, Northwestern University, Chicago, IL

Jonathan Zawadzki^1*, Debbie Jiang, MD², David A. Garcia, MD³ and Daniel E. Sabath, MD, PhD⁴

¹University of Washington School of Medicine, Seattle, WA, Seattle, WA
²Department of Hematology, University of Washington, Seattle, WA
³Division of Hematology, University of Washington, Seattle, WA
⁴Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

Julie Kanter, MD¹, Alyssa M Schlenz, PhD^2*, Martina Mueller, PhD^3*, Daniel Humphrey, MS^3*, Logan P Sirline, MPH^4*, Judson Stevens^5*, Cathy L Melvin, PhD, MPH^6*, Robert J Adams, MD, MS^7* and Shannon Phillips, PhD, RN^3*

¹Director, Adult Sickle Cell Program, University of Alabama at Birmingham, Birmingham, AL
²Pediatrics, Children's Hospital Colorado, Charleston, SC
³College of Nursing, Medical University of South Carolina, Charleston, SC
⁴Medical University of South Carolina, Charleston, SC
⁵Medpack Solutions LLC, South Charleston,, WV
⁶Public Health Sciences, Medical University of South Carolina, Charleston, SC
⁷Neurology, Medical University of South Carolina, Charleston, SC

Maria Eva Mingot-Castellano, MD, PhD^1*, Rosa Goterris, MD, PhD^2*, Moraima Jiménez, MD^3*, Valle Recasens, MD^4*, Saioa Zalba^5*, Marta Fernandez-Docampo, MD^6*, Ana Kerguelen Fuentes, MD, PhD^7*, Jose Garcia-Arroba, MD^8*, Inés Gómez-Seguí, PhMD^9*, David Valcárcel, MD, PhD¹⁰ and Cristina Pascual Izquierdo, MD, PhD^11*

¹Servicio de Hematología, Hospital Universitario Virgen del Rocío, Sevilla. Instituto de biomedicina de Sevilla (IBIS), Sevilla, Spain
²Hematology, Hospital Clinico Universitario de Valencia, Valencia, Spain
³Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
⁴Servicio de Hematología, Hospital Universitario Miguel Servet, Zaragoza, Zaragoza, AL, ESP
⁵Complejo Hospitalario de Navarra, Pamplona, Spain
⁶Servicio de Hematología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
⁷Transfusion Medicine, La Paz University Hospital-IdiPAZ, Madrid, Spain
⁸Hospital Universitario Joan XXIII, Tarragona, Spain
⁹Servicio de Hematología. Hospital La Fe, Valencia, Spain, Valencia, Spain
¹⁰Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹¹Hematology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

Taneisha Wilson, MD^1*, Katie Cherenzia, RN^2*, John L Reagan, MD^3,4,5,6, Dana L Guyer, MD^7*, Catherine Trimbur, MD^8*, Jessica Nagy, PharmD^9*, Jon Meideros, RN^10*, Andrew Buksar, RN^9*, Priscilla Eskridge^11*, David Gardner, MSN, NP^12*, Ilse Jenouri, MD^13* and Patrick T. McGann, MD, PhD^14,15

¹Alpert School of Medicine/Brown Emergency Medicine, Providence, RI
²Lifespan Cancer Institute, Brown University, Providence, RI
³Rhode Island Hospital, Providence, RI
⁴Alpert Medical School of Brown University, Providence, RI
⁵Division of Hematology/Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI
⁶Brown University, Providence, RI
⁷Alpert Medical School/Lifespan Comprehensive Sickle Cell Center, Providence, RI
⁸Lifespan, Providence, RI
⁹Lifespan/Rhode Island Hospital, Providence
¹⁰Lifespan/The Miriam Hospital, Providence
¹¹Lifespan, Providence
¹²Lifespan Cancer Center, Providence, RI
¹³Lifespan/Brown Emergency Medicine, Providence
¹⁴Lifespan Sickle Cell Center of Rhode Island, Providence, RI
¹⁵Department of Pediatrics, The Warren Alpert Medical School of Brown University, Providence, RI

Jaime M. Preussler, MS¹, Paxton Huberty, MPH^2*, Anna Desalvo, MS^2*, Katie Schoeppner, MSW, LICSW^2* and Jennifer Sees Coles, MPH^2*

¹CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/ Be the Match, Minneapolis, MN
²National Marrow Donor Program/Be The Match, Minneapolis, MN

Thorunn Thordardottir, MD, Moniba Nazeef, MD, Wendy Curran, RN MSN^* and Eva Allen, APNP^*

University of Wisconsin Hospital and Clinics, Madison, WI

Samuel T Chatio, PhD^1*, Enyonam Duah, MPH^2*, Lucy O Ababio, MB ChB^2*, Nicola Lister, MB ChB^3*, Olufolake Egbujo, MSc, MD^3*, Kwaku Marfo, MBA, PharmD, MPH^3*, Raymond Aborigo, PhD^2*, Patrick Ansah, MB ChB, MPH^2* and Isaac Odame, MD⁴

¹Navrongo Health Research Center, Navrongo, Ghana
²Navrongo Health Research Centre, Navrongo, Ghana
³Global Health & Sustainability, Novartis Pharma AG, Basel, Switzerland
⁴Hemoglobinopathy Program, The Hospital For Sick Children, University of Toronto, Toronto, ON, Canada

Anil Ananthaneni, MD¹, Udhayvir Singh Grewal, MD^1*, Tyiesha Sharron Brown, MD^2*, Zaki Al-Yafeai, MD, PhD^1*, Samip R Master, MD³ and Kavitha Beedupalli, MD^4*

¹Internal Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA
²Internal Medicine, LSU Shreveport Health, Shreveport, LA
³Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA
⁴Hematology and Oncology/Feist Weiller Cancer Center, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA

Michelle Witkop, DNP^1,2, Maria E Santaella, RN-BC, MSN, CPHON^2*, Michael Recht, MD, PhD, MBA^3,4, Keri Norris, PhD, JM, MPH, MCHES^5*, Brett Spitale^5*, Esmeralda Vasquez^5*, Donna DiMichele, MD⁶ and Kevin Mills, PhD⁷

¹National Hemophilia Foundation, National Hemophilia Foundation, Traverse city, MI
²National Hemophilia Foundation, New York, NY
³American Thrombosis and Hemostasis Network, Rochester, NY
⁴Yale University School of Medicine, Rochester, CT
⁵National Hemophilia Foundation, New York City, NY
⁶Hematology Future, Washington DC
⁷National Hemophilia Foundation, New York

Eliot A Rapoport, MD^1* and Mark Chaitowitz, MD²

¹Montefiore Medical Center, Bronx, NY
²Montefiore Medical Center, New York, NY

Chase West, BS¹, Matthew James Butler, MD², Supreet Kaur, MD³ and Anand Karnad, MD^4*

¹Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, Bellaire, TX
²UT Health Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
³UT Health Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio
⁴Division of Hematology-Oncology, UT Health Cancer Center, San Antonio, TX

Jin Han^1*, Xu Zhang, PhD^2*, Robert E. Molokie, MD³, Franklin Njoku, MD^4*, Faiz Ahmed Hussain, MD^5*, Marwah Farooqui, DO^6*, Insia Rizvi, MD^7*, Santosh L. Saraf, MD⁸ and Victor R. Gordeuk, MD⁹

¹Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
²University of Illinois At Chicago, Chicago, IL
³Department of Medicine, University of Illinois at Chicago, Jesse Brown VA Medical Center, Chicago, IL
⁴Sickle Cell Center, University of Illinois at Chicago, Chicago, IL
⁵Division of Hematology/Oncology, University of Illinois at Chicago, College of Medicine, Chicago, IL
⁶Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
⁷Department of Medicine, Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
⁸Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
⁹Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

Anna Kress, MD¹, Benjamin Lu, MD², Ayesha Butt, MBBS^3*, Jana Christian, MD^4*, Nikolai A. Podoltsev, MD, PhD¹, Michael Hurwitz, MD, PhD^5*, Sarah Goldberg, MD^5*, Barbara Burtness^2*, Iris Isufi, MD⁶, Darin Latimore^2*, Alfred I Lee, MD, PhD³ and Pamela Kunz^2*

¹Yale University School of Medicine, New Haven, CT
²Yale University School of Medicine, New Haven
³Classical Hematology, Section of Hematology, Yale University School of Medicine, New Haven, CT
⁴Department of Medicine, Yale University School of Medicine, New Haven, CT
⁵Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
⁶Hematology, Yale University School of Medicine, New Haven, CT

Sachi Singhal, MD, MBBS^1*, Anupam Baral, MD^1*, Aakash Goyal, MD^1*, Sze Jia Ng, MD^1*, Rashmika Potdar, MBBS^2*, Rahul Patel, DO^1* and Michael Styler, MD³

¹Internal Medicine, Crozer-Chester Medical Center, Upland, PA
²Crozer Chester Medical Center, Philadelphia, PA
³Bone Marrow Transplant and Cellular Therapies, Fox-Chase Medical Center, Philadelphia, PA

Lorenz Risch, MD, PhD, MPH^1,2, Galina Ludin^3*, Benjamin Sakem, PhD^3*, Urs E. Nydegger, MD^3* and Martin Risch, MD^4*

¹Dr. Risch Medical Laboratories, Vaduz, FL, Liechtenstein
²Faculty of Medical Sciences, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein
³Dr. Risch Medical Laboratories, Liebefeld, Switzerland
⁴Kantonsspital Graubünden, Chur, Switzerland

Anem Waheed, MD, MPH¹, Denise Clayton^2*, Jason Shafrin, PhD^3*, Frank Li, PhD^4*, Yulin Shi^4*, Lincy Geevarghese, MD^4* and Glorian P. Yen, PhD, MPH^4*

¹MGH Cancer Center, Hematology, Massachusetts General Hospital/Harvard Medical School, Boston, MA
²Center for Healthcare Economics and Policy, FTI Consulting, Washington, DC
³Center for Healthcare Economics and Policy, FTI Consulting, Los Angeles, CA
⁴Novartis Pharmaceuticals Corporation, East Hanover, NJ

Megan M Purser, PhD^1*, Jennifer N. Tran, DO² and Naga Jaya Smitha Yenduri, MD, MBBS^3*

¹Department of Pediatrics/Division of Psychology, Baylor College of Medicine/Texas Children's Hospital, Fulshear, TX
²Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX
³Department of Pediatrics/Division of Pediatric Pulmonology, Baylor College of Medicine/Texas Children's Hospital, Fulshear, TX

Jonathan G. Bardahl, DO¹, Monica I. Ardura, DO, MSCS^2* and Jennifer A. Rothman, MD¹

¹Division of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC
²Division of Pediatric Infectious Diseases & Host Defense Program, Nationwide Children's Hospital, Columbus, OH

Marianna C Salinas, salinasm@allegheny.edu^1*, Audrey L Fitzgerald^2*, Erika L Benson, BS^3*, Jude C Jonassaint, RN^4* and Laura Decastro, MD⁵

¹Box 2425, Meadville, PA
²University of Pittsburgh, Pittsburgh, PA
³Academic Research Center for Hematology, UPMC, Pittsburgh, PA
⁴Hillman Cancer Center, UPMC, Pittsburgh, PA
⁵Medical Center, University of Pittsburgh, Pittsburgh, PA